Comparison of 3,000 and 5,000 IU aXa/day certoparin in the prevention of deep-vein thrombosis after total hip replacement

BACKGROUND: The aim was to investigate, whether 5,000 IUaXa/day certoparin lowers the incidence of deep vein thrombosis (DVT) in patients undergoing elective hip replacement surgery vs. 3,000 IUaXa/day. Double-blind, multicenter, randomised trial in 500 patients. Primary endpoint: incidence of sympt...

Descripción completa

Detalles Bibliográficos
Autores principales: Bramlage, Peter, Michaelis, Hans-Christoph, Melzer, Nima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Original Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441324/
https://www.ncbi.nlm.nih.gov/pubmed/22713698
http://dx.doi.org/10.1186/1477-9560-10-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441324/
https://www.ncbi.nlm.nih.gov/pubmed/22713698
http://dx.doi.org/10.1186/1477-9560-10-10

Ejemplares similares